SCHEMBL30289256

SCHEMBL30289256

COC(=O)[C@@H]1CN(C(=O)OC(C)(C)C)CCN1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 2/20 0.45
MMP9 P14780 2/20 0.45
MMP3 P08254 1/20 0.45
MMP7 P09237 1/20 0.45
ALDH1A1 P00352 2/20 0.44
PDE4B Q07343 1/20 0.43
NR1H2 P55055 3/20 0.42
EPHX2 P34913 1/20 0.42
USP2 O75604 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MMP13 P45452 1/20 0.41
NR1H3 Q13133 1/20 0.41
PTPN1 P18031 2/20 0.40
EPHX1 P07099 1/20 0.40
NPC1 O15118 1/20 0.40
MAPT P10636 1/20 0.40
MAPK1 P28482 1/20 0.40
HTT P42858 1/20 0.40
RAB9A P51151 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1536817 1.00 MMP1 (0.45) MMP1MMP9MMP3MMP7ALDH1A1
SCHEMBL1536816 1.00 MMP1 (0.45) MMP1MMP9MMP3MMP7ALDH1A1
SCHEMBL19339618 0.86 PDE4B (0.43) MMP1MMP9MMP3MMP7ALDH1A1
SCHEMBL1849268 0.85 NR1H2 (0.54) MMP1MMP9MMP3MMP7ALDH1A1
SCHEMBL282661 0.85 NR1H2 (0.54) MMP1MMP9MMP3MMP7ALDH1A1
SCHEMBL919744 0.85 NR1H2 (0.54) MMP1MMP9MMP3MMP7ALDH1A1
SCHEMBL191941 0.84 USP2 (0.44) MMP1MMP9MMP3MMP7ALDH1A1
SCHEMBL4353389 0.84 USP2 (0.44) MMP1MMP9MMP3MMP7ALDH1A1
SCHEMBL28303686 0.84 USP2 (0.44) MMP1MMP9MMP3MMP7ALDH1A1
SCHEMBL27619275 0.84 ALDH1A1 (0.41) MMP1MMP9MMP3MMP7ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4405359-A2 MDM2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-07-31 EP disclosed
WO-2023049790-A2 MDM2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-03-30 WO disclosed